论文部分内容阅读
为了探讨HBsAg滴度与乙肝系列五项指标的关系,笔者对782例HBsAg阳性血清用反向间接血凝(RPHA)方法测定HBsAg滴度,并根据乙肝“两对半”阳性模式的不同归纳出6个类组。第1组(①HBsAg)26例,第2组(①HBsAg③HBsAg)43例,第3组(①HB-sAg③HBsAg⑤抗-HBc)310例,第4组(①HBsAg⑤抗-HBc)94例,第5组(①HBsAg④抗-HBe)48例,第6组(①HBsAg④抗-HBe⑤抗-HBc)261例。实验方法严格按说明书操作,每批均设试剂及阳性、阴性对照。RPHA作倍比稀释至第7孔,第8孔为空白对照,滴度大于1:128时,继续稀释至第12孔,同时作阳性、阴性及诊断血球对照。结果见表1。
In order to explore the relationship between HBsAg titer and five indicators of hepatitis B series, the authors measured HBsAg titers by reverse-indirect hemagglutination (RPHA) method in 782 HBsAg-positive sera and concluded that according to the “two and a half” positive patterns of hepatitis B 6 class groups. HBsAg (HBsAg) was detected in 26 cases in group 1, 43 cases in group 2 (H HBsAg H HBsAg), 310 cases in group 3 (H HBsAg H HBsAg 抗 anti-HBc), 94 cases in group 4 (H HBsAg 抗 anti-HBc) -HBe) 48 cases, group 6 (① HBsAg ④ anti-HBe ⑤ anti-HBc) 261 cases. Experimental methods in strict accordance with instructions, each batch of reagents and positive, negative control. RPHA diluted to the seventh hole, eighth hole blank control, titer greater than 1: 128, continue to dilute to the 12th hole, at the same time as positive, negative and diagnostic blood cell control. The results are shown in Table 1.